Lora Hedrick

5.6k total citations · 1 hit paper
30 papers, 4.1k citations indexed

About

Lora Hedrick is a scholar working on Oncology, Molecular Biology and Epidemiology. According to data from OpenAlex, Lora Hedrick has authored 30 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 12 papers in Molecular Biology and 12 papers in Epidemiology. Recurrent topics in Lora Hedrick's work include Cervical Cancer and HPV Research (10 papers), Genetic factors in colorectal cancer (10 papers) and Cancer-related Molecular Pathways (10 papers). Lora Hedrick is often cited by papers focused on Cervical Cancer and HPV Research (10 papers), Genetic factors in colorectal cancer (10 papers) and Cancer-related Molecular Pathways (10 papers). Lora Hedrick collaborates with scholars based in United States, Japan and Poland. Lora Hedrick's co-authors include Kathleen R. Cho, Theodore D. Kessis, Christina Isacson, Michael B. Kastan, Robert J.C. Slebos, Beverly Plunkett, Jonathan I. Epstein, William G. Nelson, Hironori Tashiro and Sung Min Han and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Genes & Development and The Journal of Cell Biology.

In The Last Decade

Lora Hedrick

30 papers receiving 4.0k citations

Hit Papers

DPC4 gene in various tumor types. 1996 2026 2006 2016 1996 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. DPC4 gene in various tumor types.
    1996 570 citations Lora Hedrick, Kathleen R. Cho et al. PubMed profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lora Hedrick United States 24 2.0k 1.9k 1.1k 771 740 30 4.1k
Farideh Z. Bischoff United States 35 3.1k 1.5× 3.4k 1.8× 730 0.7× 1.8k 2.3× 205 0.3× 91 7.1k
Julia A. Elvin United States 44 3.5k 1.7× 2.1k 1.1× 843 0.8× 1.3k 1.7× 484 0.7× 228 8.4k
Xavier Sastre France 33 822 0.4× 2.0k 1.0× 683 0.6× 492 0.6× 237 0.3× 77 4.2k
Michael Dictor Sweden 34 1.1k 0.5× 1.7k 0.9× 916 0.8× 341 0.4× 279 0.4× 97 3.4k
Lutz Riethdorf Germany 26 831 0.4× 1.1k 0.6× 203 0.2× 667 0.9× 673 0.9× 55 2.5k
Harald Stein Germany 19 1.1k 0.5× 1.2k 0.7× 1.1k 1.0× 499 0.6× 339 0.5× 20 4.1k
Jeffrey Sklar United States 28 1.8k 0.9× 2.6k 1.4× 1.8k 1.7× 365 0.5× 577 0.8× 54 5.2k
Denise Frosina United States 23 812 0.4× 2.3k 1.2× 436 0.4× 443 0.6× 273 0.4× 50 4.2k
Gary L. Bratthauer United States 29 917 0.4× 788 0.4× 848 0.8× 698 0.9× 209 0.3× 64 2.8k
Sibrand Poppema Netherlands 45 2.2k 1.1× 2.0k 1.1× 2.4k 2.2× 1.4k 1.8× 352 0.5× 160 6.3k

Countries citing papers authored by Lora Hedrick

Since Specialization
Citations

This map shows the geographic impact of Lora Hedrick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lora Hedrick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lora Hedrick more than expected).

Fields of papers citing papers by Lora Hedrick

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lora Hedrick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lora Hedrick. The network helps show where Lora Hedrick may publish in the future.

Co-authorship network of co-authors of Lora Hedrick

This figure shows the co-authorship network connecting the top 25 collaborators of Lora Hedrick. A scholar is included among the top collaborators of Lora Hedrick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lora Hedrick. Lora Hedrick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kendall, Brian, Brigitte M. Ronnett, Christina Isacson, et al.. (1998). Reproducibility of the Diagnosis of Endometrial Hyperplasia, Atypical Hyperplasia, and Well-Differentiated Carcinoma. The American Journal of Surgical Pathology. 22(8). 1012–1019. 183 indexed citations
2.
Cho, Kathleen R. & Lora Hedrick. (1997). Genetic Alterations in Human Tumors. Current topics in microbiology and immunology. 221. 149–176. 9 indexed citations
3.
Tashiro, Hironori, Christina Isacson, Ross L. Levine, et al.. (1997). p53 gene mutations are common in uterine serous carcinoma and occur early in their pathogenesis.. Europe PMC (PubMed Central). 150(1). 177–85. 273 indexed citations
4.
DeWeese, Theodore L., Jonathan Walsh, Larry E. Dillehay, et al.. (1997). Human papillomavirus E6 and E7 oncoproteins alter cell cycle progression but not radiosensitivity of carcinoma cells treated with low-dose-rate radiation. International Journal of Radiation Oncology*Biology*Physics. 37(1). 145–154. 60 indexed citations
5.
6.
Yonescu, Raluca, John L. Currie, Lora Hedrick, Janice Campbell, & Constance A. Griffin. (1996). Chromosome abnormalities in primary endometrioid ovarian carcinoma. Cancer Genetics and Cytogenetics. 87(2). 167–171. 8 indexed citations
7.
8.
Havre, Pamela A., Jianling Yuan, Lora Hedrick, Kathleen R. Cho, & Peter M. Glazer. (1995). p53 inactivation by HPV16 E6 results in increased mutagenesis in human cells.. PubMed. 55(19). 4420–4. 157 indexed citations
9.
Wu, T.‐C., Frank Guarnieri, Kevin F. Staveley-O’Carroll, et al.. (1995). Engineering an intracellular pathway for major histocompatibility complex class II presentation of antigens.. Proceedings of the National Academy of Sciences. 92(25). 11671–11675. 287 indexed citations
10.
Myeroff, Lois L., Ramon Parsons, Seong‐Jin Kim, et al.. (1995). A transforming growth factor beta receptor type II gene mutation common in colon and gastric but rare in endometrial cancers with microsatellite instability.. PubMed. 55(23). 5545–7. 379 indexed citations
11.
Hedrick, Lora, Kathleen R. Cho, Eric R. Fearon, et al.. (1994). The DCC gene product in cellular differentiation and colorectal tumorigenesis.. Genes & Development. 8(10). 1174–1183. 151 indexed citations
12.
Cho, Kathleen R., Jonathan W. Simons, Lora Hedrick, et al.. (1994). The DCC Gene: Structural Analysis and Mutations in Colorectal Carcinomas. Genomics. 19(3). 525–531. 172 indexed citations
13.
Cho, Kathleen R., et al.. (1994). NIH3T3 cells expressing the deleted in colorectal cancer tumor suppressor gene product stimulate neurite outgrowth in rat PC12 pheochromocytoma cells. The Journal of Cell Biology. 124(6). 1017–1027. 37 indexed citations
14.
Slebos, Robert J.C., Beverly Plunkett, Theodore D. Kessis, et al.. (1994). p53-dependent G1 arrest involves pRB-related proteins and is disrupted by the human papillomavirus 16 E7 oncoprotein.. Proceedings of the National Academy of Sciences. 91(12). 5320–5324. 293 indexed citations
15.
Hedrick, Lora, Kathleen R. Cho, & Bert Vogelstein. (1993). Cell adhesion molecules as tumour suppressors. Trends in Cell Biology. 3(2). 36–39. 64 indexed citations
16.
Kessis, Theodore D., Robert J.C. Slebos, William G. Nelson, et al.. (1993). Human papillomavirus 16 E6 expression disrupts the p53-mediated cellular response to DNA damage.. Proceedings of the National Academy of Sciences. 90(9). 3988–3992. 443 indexed citations
17.
Kessis, Theodore D., Robbert J.C. Slebos, Keerti V. Shah, et al.. (1993). p53 gene mutations and MDM2 amplification are uncommon in primary carcinomas of the uterine cervix.. PubMed. 143(5). 1398–405. 63 indexed citations
18.
Hedrick, Lora, Kathleen R. Cho, Jeff Boyd, John I. Risinger, & Bert Vogelstein. (1992). DCC: A Tumor Suppressor Gene Expressed on the Cell Surface. Cold Spring Harbor Symposia on Quantitative Biology. 57(0). 345–351. 26 indexed citations
19.
Moore, Gary, et al.. (1989). Abscess of allantoic duct remnant. American Journal of Obstetrics and Gynecology. 161(2). 334–336. 1 indexed citations
20.
Hedrick, Lora & Jonathan I. Epstein. (1989). Use of Keratin 903 as an Adjunct in the Diagnosis of Prostate Carcinoma. The American Journal of Surgical Pathology. 13(5). 389–396. 143 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Farideh Z. Bischoff Breakdown of academic impact, for papers by Julia A. Elvin Breakdown of academic impact, for papers by Xavier Sastre Breakdown of academic impact, for papers by Michael Dictor Breakdown of academic impact, for papers by Lutz Riethdorf Breakdown of academic impact, for papers by Harald Stein Breakdown of academic impact, for papers by Jeffrey Sklar Breakdown of academic impact, for papers by Denise Frosina Breakdown of academic impact, for papers by Gary L. Bratthauer Breakdown of academic impact, for papers by Sibrand Poppema
Rankless by CCL
2026